Vedder Price

Ryan S. Hedges

Shareholder

Ryan S. Hedges is a Shareholder in the Litigation practice area at Vedder Price and a member of the firm’s Chambers USA–ranked Government Enforcement & Special Investigations group, focusing on white collar defense, internal investigations and complex litigation matters.

A former federal prosecutor and experienced trial lawyer, Mr. Hedges has successfully tried numerous federal criminal cases for and against the government. Mr. Hedges represents companies and individuals in criminal and regulatory proceedings involving the U.S. Department of Justice (DOJ), Securities and Exchange Commission (SEC), Department of Health and Human Services (HHS-OIG), and other government agencies.

Mr. Hedges also conducts internal investigations into possible wrongdoing and counsels clients regarding compliance in the areas of health care, the Anti-Kickback Statute (AKS), securities laws, the Foreign Corrupt Practices Act (FCPA), the False Claims Act (FCA) and in connection with transaction due diligence.

Prior to joining Vedder Price, Mr. Hedges served for more than seven years as an Assistant U.S. Attorney in Chicago investigating and prosecuting complex financial crimes including health care fraud; investment, securities and commodities fraud; mail and wire fraud; bank fraud; money laundering; and tax crimes. Selected to the U.S. Attorney’s team dedicated to prosecuting health care fraud, Mr. Hedges investigated and prosecuted some of the largest and most complex health care fraud cases recently charged in the Northern District of Illinois. Most notably, Mr. Hedges co-led the multi-year investigation and resulting prosecution of eleven administrators and doctors at the former Sacred Heart Hospital, which culminated in 2015 with a seven-week jury trial and guilty verdicts against the hospital’s CEO and two other top administrators. This case received the prestigious Investigations Award for Excellence from the Council for the Inspectors General on Integrity and Efficiency (CIGIE) after nomination by HHS-OIG.

Mr. Hedges previously served as a law clerk to the Honorable Kim McLane Wardlaw of the U.S. Court of Appeals for the Ninth Circuit. While in law school, Mr. Hedges served as Editor-in-Chief of the Southern California Law Review.


Ryan S. Hedges

Shareholder

Experience

Representative matters include:

  • Conducting internal investigations for publicly traded and privately held companies and representing those clients in government-facing matters regarding potential violations of health care fraud laws and the FCA, securities laws and the FCPA, federal procurement and environmental laws
  • Representing sales executive of a publicly traded automobile manufacturer in parallel SEC and DOJ investigations into the manufacturer’s sales reporting
  • Representing current and former officers and directors of publicly traded companies in parallel SEC and DOJ investigations into alleged insider trading
  • Representing home health agencies (HHA) and their owners in DOJ investigations into insurance billing and marketing practices
  • Lead counsel to the “Information Agent” appointed in U.S. v. All Business Assets of the Viceroy L’Ermitage Beverly Hills (C.D. Cal. Case No. 16-cv-5369, relating to the alleged multi-billion-dollar 1MDB fraud)
  • Representing former CFO of publicly traded pharmaceutical company in connection with parallel SEC and DOJ investigations into the company’s financial reporting and accounting practices
  • Representing a national accounting firm and its accounting professionals as third parties in connection with the prosecution of a pharmaceutical executive and his lawyer on charges of conspiracy to commit wire fraud and securities fraud, U.S. v. Martin Shkreli and Evan Greebel (E.D.N.Y. Case No. 15-637)
  • Representing a third-party investment advisor in federal criminal forfeiture proceedings against one of its former clients following his conviction for federal health care fraud offenses
  • Represented dozens of employees of various hospital systems in connection with grand jury investigations and their third-party trial testimony regarding federal health care fraud charges
  • Successfully represented a medical billing company and its president in a federal qui tam lawsuit alleging FCA violations
  • Conducted an internal investigation for a home health company related to alleged FCA and Stark Law violations
  • Represented a refinery charged with criminal violations of the federal Clean Air Act in a six-week jury trial, obtaining acquittals on two of four counts, with the two counts of conviction ultimately being reversed on appeal
  • Represented a refinery in a grand jury investigation into potential violations of the federal Clean Water Act, resulting in no criminal charges
  • Routinely conducts investigations and provides guidance related to substantive health care matters, including Medicare and Medicaid fraud and abuse; medical insurance billing; up-coding and over-billing; unlawful kickbacks; physician compensation arrangements; patient referral practices; off-label promotion and misbranding of pharmaceuticals, dietary supplements and medical devices; and regulatory compliance with the AKS, FCA, Stark Law, and Food, Drug and Cosmetic Act (FDCA), among other federal statutes

Ryan S. Hedges

Shareholder

Education

  • University of Southern California Gould School of Law, J.D., 2001
  • Northwestern University, B.S., 1993

Ryan S. Hedges

Shareholder

Bar Admissions

  • California, 2001
  • Illinois, 2005

Court Admissions

  • U.S. District Court, Central District of California, 2001
  • U.S. District Court, Eastern District of California, 2002
  • U.S. District Court, Northern District of Illinois, 2005
  • U.S. District Court, Northern District of Illinois Trial Bar, 2007
  • U.S. Court of Appeals, Ninth Circuit, 2002
  • U.S. Court of Appeals, Seventh Circuit, 2006

Affiliations

  • Member, American Bar Association
  • Member, Federal Bar Association

Ryan S. Hedges

Shareholder

Ryan S. Hedges

Shareholder

Blogs

Mr. Hedges contributes to our Media & Privacy Risk Report blog. To view it, please click here.